ClariVest Asset Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-103,300
| Closed | -$603K | – | 788 |
|
|
2022
Q4 | $603K | Sell |
103,300
-1,500
| -1% | -$8.76K | 0.03% | 361 |
|
|
2022
Q3 | $702K | Hold |
104,800
| – | – | 0.03% | 312 |
|
|
2022
Q2 | $441K | Buy |
+104,800
| New | +$441K | 0.02% | 390 |
|
|
2019
Q2 | – | Sell |
-31,900
| Closed | -$385K | – | 769 |
|
|
2019
Q1 | $385K | Sell |
31,900
-97,306
| -75% | -$1.17M | 0.01% | 474 |
|
|
2018
Q4 | $1.62M | Buy |
129,206
+20,294
| +19% | +$255K | 0.03% | 336 |
|
|
2018
Q3 | $1.62M | Buy |
108,912
+2,970
| +3% | +$44.1K | 0.03% | 353 |
|
|
2018
Q2 | $1.78M | Sell |
105,942
-2,710
| -2% | -$45.6K | 0.03% | 358 |
|
|
2018
Q1 | $2.49M | Buy |
108,652
+94,334
| +659% | +$2.16M | 0.04% | 309 |
|
|
2017
Q4 | $370K | Buy |
+14,318
| New | +$370K | 0.01% | 521 |
|